Advancements in imaging technology and analysis methods are expected to enhance the utility of DCE MRI in cancer care. Integration with other imaging modalities, such as PET and CT, can provide a more comprehensive understanding of tumor biology. Furthermore, the development of new contrast agents and automated analysis software will likely improve the accuracy and accessibility of DCE MRI, making it an even more valuable tool in the fight against cancer.
